This company listing is no longer active
2176 Stock Overview
Ina Research Inc., a consulting company, provides non-clinical and clinical studies services primarily in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Ina Research Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥899.00 |
| 52 Week High | JP¥900.00 |
| 52 Week Low | JP¥566.00 |
| Beta | 0 |
| 1 Month Change | 0.11% |
| 3 Month Change | 35.19% |
| 1 Year Change | 27.70% |
| 3 Year Change | 27.52% |
| 5 Year Change | 32.60% |
| Change since IPO | -73.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2176 | JP Life Sciences | JP Market | |
|---|---|---|---|
| 7D | 0.1% | -0.4% | -2.6% |
| 1Y | 27.7% | -33.6% | 28.4% |
Return vs Industry: 2176 exceeded the JP Life Sciences industry which returned 14.6% over the past year.
Return vs Market: 2176 exceeded the JP Market which returned -1.8% over the past year.
Price Volatility
| 2176 volatility | |
|---|---|
| 2176 Average Weekly Movement | 7.7% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 8.2% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 2176's share price has been volatile over the past 3 months.
Volatility Over Time: 2176's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | n/a | Kenji Nakagawa | www.ina-research.co.jp |
Ina Research Inc., a consulting company, provides non-clinical and clinical studies services primarily in Japan. It offers Toxicology, Safety Pharmacology, Drug Dependence, Drug Efficacy, and QT/QTc studies, as well as support services for a range of non-clinical toxicity studies for pharmaceutical development, from the screening stage to preparation for clinical trials. The company also provides safety assessment of chemicals and agrichemicals.
Ina Research Inc. Fundamentals Summary
| 2176 fundamental statistics | |
|---|---|
| Market cap | JP¥2.69b |
| Earnings (TTM) | JP¥141.00m |
| Revenue (TTM) | JP¥2.43b |
0.0x
P/E Ratio0.0x
P/S RatioIs 2176 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2176 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.43b |
| Cost of Revenue | JP¥1.72b |
| Gross Profit | JP¥710.00m |
| Other Expenses | JP¥569.00m |
| Earnings | JP¥141.00m |
Last Reported Earnings
Mar 31, 2018
Next Earnings Date
Aug 10, 2022
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 2176 perform over the long term?
See historical performance and comparison